Literature DB >> 17530212

[MR spectroscopy in brain tumors].

P Papanagiotou1, M Backens, I Q Grunwald, G Farmakis, M Politi, C Roth, W Reith.   

Abstract

MRT allows the anatomical visualization of intracerebral space-occupying lesions, and when magnetic resonance spectroscopy (MRS) is used in routine clinical practice it can give more information and be helpful in the diagnosis of such lesions. In MRS with long echo times for nerve tissue there are five metabolites that are particularly significant: N-acetyl aspartate (NAA), creatine, choline, lactate, and lipids. NAA levels are lowered in the presence of intracerebral tumors. Creatine is lowered in situations of hypermetabolic metabolism and elevated in hypometabolic conditions, but remains constant in many pathologic states and can be used as a reliable reference value. With malignant tumors there are usually elevated choline concentrations, reflecting increased membrane synthesis and a higher cell turnover. The lactate level rises following a switch in metabolism from aerobic to anaerobic glycolysis, and this is frequently observed in the presence of malignant tumors. The occurrence of lipid peaks in a tumor spectrum suggests the presence of tissue necroses or metastases. There are typical constellations that are seen on MRS for individual tumors, which are discussed in detail in the present paper.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17530212     DOI: 10.1007/s00117-007-1522-8

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  20 in total

Review 1.  MR spectroscopy of brain tumors.

Authors:  Meng Law
Journal:  Top Magn Reson Imaging       Date:  2004-10

Review 2.  Localized MR spectroscopy: basic principles.

Authors:  L Kwock
Journal:  Neuroimaging Clin N Am       Date:  1998-11       Impact factor: 2.264

3.  Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors.

Authors:  M A Weber; S Zoubaa; M Schlieter; E Jüttler; H B Huttner; K Geletneky; C Ittrich; M P Lichy; A Kroll; J Debus; F L Giesel; M Hartmann; M Essig
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

4.  Magnetic resonance imaging in five patients with a tumefactive demyelinating lesion in the central nervous system.

Authors:  H C Silva; D Callegaro; P E Marchiori; M Scaff; A M Tsanaclis
Journal:  Arq Neuropsiquiatr       Date:  1999-12       Impact factor: 1.420

5.  Clinical MR spectroscopy: fundamentals, current applications, and future potential.

Authors:  J P Cousins
Journal:  AJR Am J Roentgenol       Date:  1995-06       Impact factor: 3.959

6.  Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks.

Authors:  H Poptani; J Kaartinen; R K Gupta; M Niemitz; Y Hiltunen; R A Kauppinen
Journal:  J Cancer Res Clin Oncol       Date:  1999       Impact factor: 4.553

7.  Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.

Authors:  D L Arnold; P M Matthews; G S Francis; J O'Connor; J P Antel
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

Review 8.  Clinical applications of proton MR spectroscopy in oncology.

Authors:  Lester Kwock; J Keith Smith; Mauricio Castillo; Matthew G Ewend; Sharon Cush; Thomas Hensing; Mahesh Varia; David Morris; Thomas W Bouldin
Journal:  Technol Cancer Res Treat       Date:  2002-02

9.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.

Authors:  F A Howe; S J Barton; S A Cudlip; M Stubbs; D E Saunders; M Murphy; P Wilkins; K S Opstad; V L Doyle; M A McLean; B A Bell; J R Griffiths
Journal:  Magn Reson Med       Date:  2003-02       Impact factor: 4.668

10.  Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data.

Authors:  Sebastian Herminghaus; Thomas Dierks; Ulrich Pilatus; Walter Möller-Hartmann; Jörg Wittsack; Gerhard Marquardt; Christoph Labisch; Heinrich Lanfermann; Wolfgang Schlote; Friedhelm E Zanella
Journal:  J Neurosurg       Date:  2003-01       Impact factor: 5.115

View more
  9 in total

1.  [Value of MR spectroscopy in infectious and inflammatory brain diseases].

Authors:  P Papanagiotou; K I Schmidt; M Alexandrou; H Körner; W Reith
Journal:  Radiologe       Date:  2010-09       Impact factor: 0.635

Review 2.  [Magnetic resonance spectroscopy for inflammatory brain diseases].

Authors:  P Papanagiotou; I Q Grunwald; G Farmakis; K M Hartmann; M Politi; C Roth; W Reith
Journal:  Radiologe       Date:  2008-06       Impact factor: 0.635

Review 3.  [Acute disseminated encephalomyelitis].

Authors:  M Politi; P Papanagiotou; I Q Grunwald; C Roth; W Reith
Journal:  Radiologe       Date:  2008-06       Impact factor: 0.635

4.  [Magnetic resonance spectroscopy of brain tumors].

Authors:  P Ditter; E Hattingen
Journal:  Radiologe       Date:  2017-06       Impact factor: 0.635

5.  [Intra-axial brain tumors].

Authors:  P Papanagiotou
Journal:  Radiologe       Date:  2012-06       Impact factor: 0.635

Review 6.  [Tumors of the posterior cranial fossa].

Authors:  P Papanagiotou; M Politi
Journal:  Radiologe       Date:  2016-11       Impact factor: 0.635

Review 7.  [Pediatric brain tumors of neuroepithelial tissue].

Authors:  P Papanagiotou; M Bergmann; A Pekrun; K U Juergens; M Politi
Journal:  Radiologe       Date:  2014-08       Impact factor: 0.635

Review 8.  [Intra-axial brain tumors in adults : On the basis of the 2016 WHO classification].

Authors:  N Peitgen; P Papanagiotou
Journal:  Radiologe       Date:  2017-09       Impact factor: 0.635

9.  Proton magnetic resonance spectroscopy of periventricular white matter and hippocampus in obstructive sleep apnea patients.

Authors:  Volkan Kızılgöz; Hasan Aydın; Idil Güneş Tatar; Baki Hekimoğlu; Sadık Ardıç; Hikmet Fırat; Cem Dönmez
Journal:  Pol J Radiol       Date:  2013-11-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.